Compugen (CGEN) Profit After Tax (2009 - 2026)
Compugen (CGEN) posted quarterly Profit After Tax of $7.7 million for Q1 2026, up 6.8% year-over-year from $7.2 million in Q1 2025, and down 86.48% on a QoQ basis from $56.7 million in Q4 2025.
Analysis
Compugen (CGEN) Profit After Tax (2009 - 2026) Analysis & Trends
Compugen has reported Profit After Tax for 18 years, with the latest figure at $7.7 million in Q1 2026.
- Profit After Tax for Q1 2026 came in at $7.7 million, up 6.8% year-over-year; the trailing twelve-month figure through Mar 2026 was $35.8 million (up 774.38% YoY), and the FY2025 annual result was $35.3 million, up 348.35% from the prior year.
- Profit After Tax eased to $7.7 million in Q1 2026, from $56.7 million in the prior quarter.
- Over five years, Profit After Tax peaked at $56.7 million in Q4 2025 and troughed at -$28.0 million in Q2 2023.
- A 5-year average of $1.4 million and a median of -$3.1 million in 2022 frame the typical range for Profit After Tax.
- The widest annual swing landed in 2023, when Profit After Tax tumbled 197.86%; it then jumped 1027.53% in 2025.
- A 5-year view of Profit After Tax shows it stood at -$3.1 million in 2022, then jumped by 414.13% to $9.7 million in 2023, then slumped by 162.98% to -$6.1 million in 2024, then jumped by 1027.53% to $56.7 million in 2025, then plunged by 86.48% to $7.7 million in 2026.
- Per Business Quant data, the three most recent Profit After Tax figures were $7.7 million in Q1 2026, $56.7 million in Q4 2025, and -$6.9 million in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 1.10 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 1.30 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | 472.00 Mn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | -782.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | -644.37 Mn |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 237.01 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 164.49 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 81.49 Mn |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | -16.62 Mn |
| 10 | Compugen | 242.44 Mn | 156.82 Mn | -92,000.00 | -22.34 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -22.34 Mn |
| Mar 31, 2026 | 7.67 Mn |
| Dec 31, 2025 | 56.85 Mn |
| Sep 30, 2025 | -6.98 Mn |
| Jun 30, 2025 | -21.70 Mn |
| Mar 31, 2025 | 7.18 Mn |
| Dec 31, 2024 | -6.12 Mn |
| Sep 30, 2024 | 1.28 Mn |
| Jun 30, 2024 | -16.66 Mn |
| Mar 31, 2024 | 7.27 Mn |
| Dec 31, 2023 | 9.71 Mn |
| Sep 30, 2023 | -9.85 Mn |
| Jun 30, 2023 | -27.95 Mn |
| Mar 31, 2023 | 9.34 Mn |
| Dec 31, 2022 | -3.09 Mn |
| Sep 30, 2022 | -11.75 Mn |
| Jun 30, 2022 | 28.56 Mn |
| Mar 31, 2022 | -9.71 Mn |
| Dec 31, 2021 | -8.65 Mn |
| Sep 30, 2021 | -6.16 Mn |